AGC
AGN

Angelo Gordon & Co’s Allergan plc AGN Stock Holding History

Angelo Gordon & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-225,000
Closed -$39.8M – 95
2020
Q1 		$39.8M Sell
225,000
-225,000
-50% -$42.4M 2.97% 5
2019
Q4 		$86M Hold
450,000
– – 13.29% 2
2019
Q3 		$75.7M Buy
450,000
+325,000
+260% +$52.9M 9.66% 2
2019
Q2 		$20.9M Buy
+125,000
New +$17.3M 2.39% 11
2016
Q2 		– Sell
-60,000
Closed -$16.1M – 61
2016
Q1 		$16.1M Buy
+60,000
New +$17.2M 1.16% 21

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Angelo Gordon & Co's AGN Position: Q2 2020 in Review

Angelo Gordon & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 225,000 shares — an estimated $39.8M sold.

Angelo Gordon & Co first reported a position in AGN in Q1 2016 and held it in 5 quarters. The position peaked at $86M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Angelo Gordon & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Angelo Gordon & Co sold 225,000 Allergan plc shares in Q2 2020, an estimated $39.8M.
  • Angelo Gordon & Co first reported a position in Allergan plc in Q1 2016 and held it in 5 quarters.
  • Angelo Gordon & Co's Allergan plc position peaked at $86M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Angelo Gordon & Co's 13F filing for Q2 2020, filed 14 Aug 2020.